“With the healthcare landscape constantly evolving, especially in areas related to precision medicine, hospitals and health systems need comprehensive solutions to present complete patient information quickly and accurately,” said Louis Culot, General Manager, Oncology Informatics, Philips. “At Philips, we’re committed to partnering with leading cancer centers like Miami Cancer Institute at Baptist Health to bring the highest level of precision diagnosis to cancer treatment options to help improve clinical quality, and reduce costs to treat patients more effectively early in their cancer care journey.”
IntelliSpace Precision Medicine Genomics is powered by Philips HealthSuite, enabling health systems to make informed, secure and timely decisions, in the right place at the right time. The Philips HealthSuite digital platform is a cloud-based, open platform of services, capabilities and tools designed to inspire and enable the development of next generation connected health innovations.
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Philips at HIMSS
For more information on Philips’ full portfolio of integrated smart systems, devices, software and services that will be spotlighted at the upcoming HIMSS Global Conference & Exhibition in Orlando, FL, Feb. 11-15, 2019, visit www.philips.com/himss and follow @PhilipsLiveFrom for #HIMSS19 updates throughout the event.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
About Miami Cancer Institute
Miami Cancer Institute is a next-generation cancer treatment destination known for its leading clinical care and research, compassionate patient experience and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean, and the only radiation oncology program in the world with each of the latest radiation therapies in one place. The Institute offers an impressive roster of established community oncologists and renowned cancer experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. As Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management teams match those at MSK. Heralded nationally as one of the “hybrid” cancer centers of the future, Miami Cancer Institute combines high-quality community-based cancer care with the best of an academic cancer center, including innovative clinical trials tied to research and genomics and disease-specific surgeons, medical oncologists and radiation oncologists who are experts in their fields. For more information, visit MiamiCancerInstitute.com.
Back to HCB News
